Branson BM, Handsfield HH, Lampe MA, et al. Revised recommendations for HIV testing of adults, adolescents, and pregnant women in health-care settings. MMWR. 2006;55(9):1–17.
Moyer VA. U.S. preventive services task force. screening for HIV: U.S. Preventive services task force recommendation statement. Ann Intern Med. 2013;159(1):51–60.
Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents. Department of Health and Human Services. May 1, 2014:D1-E47. Available at: http://www.aidsinfo.nih.gov/contentfiles/lvguidelines/adultandadolescentgl.pdf.
Centers for Disease Control and Prevention. Expanded testing program—overview. Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention; August 2011.
Centers for Disease Control and Prevention. High-impact HIV prevention: CDC’s approach to reducing HIV infections in the United States. Available at: http://www.cdc.gov/hiv/policies/hip.html. Accessed March 17, 2015.
Health Resources and Services Administration. HRSA care action: high-impact prevention. Available at: http://hab.hrsa.gov/deliverhivaidscare/files/high_impact_prevention.pdf. Accessed March 17, 2015.
Hutchinson AB, Farnham PG, Duffy N, et al. Return on public health investment: CDC’s expanded HIV testing initiative. J Acquir Immune Defic Syndr. 2012;59(3):281–6.
Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. NEJM. 2011;365(6):493–505.
Centers for Disease Control and Prevention. HIV testing trends in the United States, 2000–2011. Atlanta, GA: U.S. Department of Health and Human Services, January 2013:1–35. Available at: http://www.cdc.gov/hiv/pdf/testing_trends.pdf. Accessed March 17, 2015.
Cooley LA, Oster AM, Rose CE, et al. Increases in HIV testing among men who have sex with men—national HIV behavioral surveillance system, 20 U.S. metropolitan statistical areas, 2008 and 2011. PLoS ONE. 2014;9(9):e104162. doi:10.1371/journal.pone.0104162.
Centers for Disease Control and Prevention. Monitoring selected national HIV prevention and care objectives by using HIV surveillance data—United States and 6 dependent areas—2012. HIV Surveillance Supplemental Report 2014;19(3). http://www.cdc.gov/hiv/library/reports/surveillance/. Published November 2014. Accessed February 4, 2015.
Centers for Disease Control and Prevention. HIV surveillance report, 2013; 25:76. Available at: http://www.cdc.gov/hiv/library/reports/surveillance/. Published February 2015. Accessed May 17, 2015.
Valdiserri RO, Forsyth AD, Yakovchenko V, Koh HK. Measuring what matters: development of standard HIV core indicators across the U.S. Department of Health and Human Services. Public Health Rep. 2013;128(5):354–9.
U.S. Department of Health and Human Services, Office of Disease Prevention and Health Promotion. Healthy People 2020 Objectives. HIV-9 Reduce the proportion of persons with a diagnosis of Stage 3 HIV (AIDS) within 3 months of diagnosis of HIV infection. Available at: https://www.healthypeople.gov/2020/topics-objectives/topic/hiv/objectives. Accessed March 17, 2015.
Selik RM, Mokotoff ED, Branson B, Owen SM, Whitmore S, Hall HI. Revised surveillance case definition for HIV infection—United States, 2014. MMWR. 2014;63(RR03):1–10.
Office of Management and Budget. Revised definitions of metropolitan statistical areas, new definitions of micropolitan statistical areas and combined statistical areas, and guidance on uses of the delineations of these areas. OMB Bulletin 13-01. http://go.usa.gov/vSyB. Published February 28, 2013. Accessed December 1, 2014.
McDavid Harrison K, Kajese T, Hall HI, Song R. Risk factor redistribution of the national HIV/AIDS surveillance data: an alternative approach. Public Health Rep. 2008;123(5):618–27.
Hall HI, Song R, Szwarcwald CL, Green T. Time from infection with the human immunodeficiency virus to diagnosis, United States. J Acquir Immune Defic Syndr. 2015;6992:248–51.
Lesko CR, Cole SR, Zinski A, Poole C, Mugavero MJ. A Systematic review and meta-regression of temporal trends in adult CD4+ cell count at presentation to HIV care, 1992–2011. Clin Infect Dis. 2013;57(7):1027–37.
Gray KM, Branson B, Donnell DJ, Beauchamp G, Hu X, Wang Z, El Sadr W, Hall HI. HIV testing in six US cities using behavioral surveillance data for the TLC-Plus (HPTN 065) study. XIX International AIDS Conference. Washington, 2012 [abstract TUPE 293].
Centers for Disease Control and Prevention. Results of the expanded HIV testing initiative—25 Jurisdictions, United States, 2007–2010. MMWR. 2011;60(24):805–10.
Cooley LA, Wejnert C, Rose CE, Paz-Bailey G, National HIV. Behavioral surveillance study group. Increases in recent HIV testing among men who have sex with men coincide with the centers for disease control and prevention’s expanded testing initiative. Clin Infect Dis. 2015;60(3):483–5.
Burns DN, DeGruttola V, Pilcher CD, et al. Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retrovir. 2014;30(4):217–24.
Xia Q, Kobrak P, Wiewel EW, Torian LV. The high proportion of late HIV diagnoses in the USA is likely to stay: findings from a mathematical model. AIDS Care. 2015;27(2):206–12.
Xia Q, Torian LV, Shepard CW. Limitations of Indicators of HIV case Finding. Epidemiology. 2015;26(1):e6–8.
Hayek S; Dietz PM, Van Handel M, et al. Centers for Disease Control and Prevention funding for HIV testing associated with higher state percentage of persons tested. J Public Health Manag Pract. 2015 Feb 12. [Epub ahead of print].